Orally delivered vaccines - what does the future hold? Newsletter Article 13 February 2013 Pages: 5 - 5
First ET-receptor antagonist ready for clinical studies Newsletter Article 13 February 2013 Pages: 6 - 6
A breakthrough for migraine - a burden for the health bill? Newsletter Article 13 February 2013 Pages: 10 - 10
Ceftazidime costs less when renal dysfunction is present Newsletter Article 13 February 2013 Pages: 11 - 11
Gene therapy - the way of the future, but who will pay? Newsletter Article 13 February 2013 Pages: 11 - 11
Reduce duration of treatment for traveler’s diarrhoea Newsletter Article 13 February 2013 Pages: 11 - 11
Trials of acupuncture in asthma are of poor quality Newsletter Article 13 February 2013 Pages: 13 - 13
Parallel analysis verifies that tacrine works in Alzheimer’s disease Newsletter Article 13 February 2013 Pages: 15 - 15
New method of drug administration for RA of the hand Newsletter Article 13 February 2013 Pages: 15 - 15
New guidelines for antihypercholesterolaemics awaited Newsletter Article 13 February 2013 Pages: 16 - 17
Endoperoxide shift causes aspirin-induced decrease in prostacyclin Newsletter Article 13 February 2013 Pages: 19 - 19
Mexiletine and quinidine have very different haemodynamic effects Newsletter Article 13 February 2013 Pages: 20 - 20
The Institute of Medicine reports on DPT and rubella vaccine safety Newsletter Article 13 February 2013 Pages: 20 - 20
